Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction
- 1 March 1991
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 67 (6) , 496-500
- https://doi.org/10.1016/0002-9149(91)90010-i
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Factors associated with pericardial effusion in acute Q wave myocardial infarction.Circulation, 1990
- Administration of thrombolytic therapy in the community hospital: Established principles and unresolved issuesJournal of the American College of Cardiology, 1988
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Incidence and significance of pericardial effusion in acute myocardial infarction as determined by two-dimensional echocardiographyJournal of the American College of Cardiology, 1986
- Pericardial effusion in the course of myocardial infarction: incidence, natural history, and clinical relevance.Circulation, 1986
- Constrictive pericarditis after myocardial infarction. Sequela of anticoagulant-induced hemopericardiumThe American Journal of Medicine, 1985
- Frequency of pericardial effusion as determined by M-mode echocardiography in acute myocardial infarctionThe American Journal of Cardiology, 1985
- Cardiac tamponade in medical patients.Circulation, 1981
- HEMOPERICARDIUM WITH TAMPONADE DURING ANTICOAGULANT THERAPY OF MYOCARDIAL INFARCTJAMA, 1953
- HEMORRHAGIC PERICARDITIS IN ACUTE MYOCARDIAL INFARCTION TREATED WITH BISHYDROXYCOUMARINJAMA, 1951